ROS1 rearrangement: the latest class of non-small-cell lung cancer tumor

被引：0
|
作者：
Miller, Sarah
机构：
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] ROS1 rearrangement: the latest class of non-small-cell lung cancer tumor
    Miller, Sarah
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (04) : 427 - 427
  • [2] Progress of non-small-cell lung cancer with ROS1 rearrangement
    Yang, Xin
    Tang, Zhe
    Li, Jing
    Jiang, Jizong
    Liu, Yue
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [3] Detection of ROS1 rearrangement in circulating tumor cells in ROS1-positive non-small-cell lung cancer patients
    Pailler, Emma
    Besse, Benjamin
    Zajac, Olivier
    Coudert, Benoit
    Soria, Jean-Charles
    Farace, Francoise
    CANCER RESEARCH, 2014, 74 (19)
  • [4] ROS1 rearrangement coexists with EGFR mutation in non-small-cell lung cancer.
    Chen, Rui-lian
    Yang, Jin-Ji
    Zhang, Xu-Chao
    Lou, Na-na
    Chen, Huajun
    Zhou, Qing
    Su, Jian
    Guo, Weibang
    Chen, Jian-guang
    Tu, Haiyan
    Sun, Yueli
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] ROS1 fusions in Chinese patients with non-small-cell lung cancer
    Cai, W.
    Li, X.
    Su, C.
    Fan, L.
    Zheng, L.
    Fei, K.
    Zhou, C.
    Manegold, C.
    Schmid-Bindert, G.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1822 - 1827
  • [6] CLINICAL ACTIVITY OF CRIZOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) HARBORING ROS1 GENE REARRANGEMENT
    Bang, Y. -J.
    Ou, S.
    Camidge, D. R.
    Clark, J. W.
    Wilner, K.
    Tye, L.
    Stephenson, P.
    Varella-Garcia, M.
    Iafrate, A. J.
    Shaw, A. T.
    ANNALS OF ONCOLOGY, 2012, 23 : 33 - 33
  • [7] Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
    Drilon, Alexander
    Camidge, D. Ross
    Lin, Jessica J.
    Kim, Sang-We
    Solomon, Benjamin J.
    Dziadziuszko, Rafal
    Besse, Benjamin
    Goto, Koichi
    de Langen, Adrianus Johannes
    Wolf, Juergen
    Lee, Ki Hyeong
    Popat, Sanjay
    Springfeld, Christoph
    Nagasaka, Misako
    Felip, Enriqueta
    Yang, Nong
    Velcheti, Vamsidhar
    Lu, Shun
    Kao, Steven
    Dooms, Christophe
    Krebs, Matthew G.
    Yao, Wenxiu
    Beg, Muhammad Shaalan
    Hu, Xiufeng
    Moro-Sibilot, Denis
    Cheema, Parneet
    Stopatschinskaja, Shanna
    Mehta, Minal
    Trone, Denise
    Graber, Armin
    Sims, Gregory
    Yuan, Yong
    Cho, Byoung Chul
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (02): : 118 - 131
  • [8] ROS1 Immunohistochemistry Among Major Genotypes of Non-Small-Cell Lung Cancer
    Boyle, Theresa A.
    Masago, Katsuhiro
    Ellison, Kim E.
    Yatabe, Yasushi
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2015, 16 (02) : 106 - 111
  • [9] Validating ROS1 Rearrangements As a Therapeutic Target in Non-Small-Cell Lung Cancer
    Solomon, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 972 - 974
  • [10] Clinicopathological significance and diagnostic approach of ROS1 rearrangement in non-small cell lung cancer: a meta-analysis: ROS1 in non-small cell lung cancer
    Yang, Jungho
    Pyo, Jung-Soo
    Kang, Guhyun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (04): : 520 - 527
12345